Comparison of doses received by the hippocampus in patients treated with single isocenter- vs multiple isocenter-based stereotactic radiation therapy to the brain for multiple brain metastases

• Published in: Medical dosimetry : official journal of the American Association of Medical Dosimetrists Vol. 40; no. 4; p. 314
• Main Authors: Algan, Ozer, Giem, Jared, Young, Julie, Ali, Imad, Ahmad, Salahuddin, Hossain, Sabbir
• Format: Journal Article
• Language: English
• Published: United States 2015
• Subjects: Adult; Aged; Aged, 80 and over; Brain Neoplasms - radiotherapy; Brain Neoplasms - secondary; Female; Hippocampus; Humans; Male; Middle Aged; Radiation Dosage; Radiosurgery - methods; Stereotactic radiosurgery; Hippocampal doses; Single isocenter; Multiple isocenter; DVH analysis
• ISSN: 1873-4022
• DOI: 10.1016/j.meddos.2015.04.001

To investigate the doses received by the hippocampus and normal brain tissue during a course of stereotactic radiation therapy using a single isocenter (SI)-based or multiple isocenter (MI)-based treatment planning in patients with less than 4 brain metastases. In total, 10 patients with magnetic resonance imaging (MRI) demonstrating 2-3 brain metastases were included in this retrospective study, and 2 sets of stereotactic intensity-modulated radiation therapy (IMRT) treatment plans (SI vs MI) were generated. The hippocampus was contoured on SPGR sequences, and doses received by the hippocampus and the brain were calculated and compared between the 2 treatment techniques. A total of 23 lesions in 10 patients were evaluated. The median tumor volume, the right hippocampus volume, and the left hippocampus volume were 3.15, 3.24, and 2.63mL, respectively. In comparing the 2 treatment plans, there was no difference in the planning target volume (PTV) coverage except in the tail for the dose-volume histogram (DVH) curve. The only statistically significant dosimetric parameter was the V100. All of the other measured dosimetric parameters including the V95, V99, and D100 were not significantly different between the 2 treatment planning techniques. None of the dosimetric parameters evaluated for the hippocampus revealed any statistically significant difference between the MI and SI plans. The total brain doses were slightly higher in the SI plans, especially in the lower dose region, although this difference was not statistically different. The use of SI-based treatment plan resulted in a 35% reduction in beam-on time. The use of SI treatments for patients with up to 3 brain metastases produces similar PTV coverage and similar normal tissue doses to the hippocampus and the brain when compared with MI plans. SI treatment planning should be considered in patients with multiple brain metastases undergoing stereotactic treatment.